The SMI showed resilience amid a technical recovery, while UBS and Polypeptide faced declines, and Tecan experienced pressure. In China, the Caixin/S&P Global PMI for manufacturing improved in October, indicating a gradual economic recovery, though challenges in the labor market and subdued prices persist. Achieving the 2024 growth target hinges on boosting consumer demand and household disposable income, according to economist Wang Zhe. The Shanghai Stock Exchange rose 0.6% to 3,299.61 points, with major companies' index up 0.9% to 3,924.96 points.